BE717950A - - Google Patents

Info

Publication number
BE717950A
BE717950A BE717950DA BE717950A BE 717950 A BE717950 A BE 717950A BE 717950D A BE717950D A BE 717950DA BE 717950 A BE717950 A BE 717950A
Authority
BE
Belgium
Prior art keywords
emi
process according
reduction
carried out
acid
Prior art date
Application number
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE717950A publication Critical patent/BE717950A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20—[b, f]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BE717950D 1967-07-11 1968-07-11 BE717950A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DET0034302 1967-07-11

Publications (1)

Publication Number Publication Date
BE717950A true BE717950A (de) 1969-01-13

Family

ID=7558396

Family Applications (1)

Application Number Title Priority Date Filing Date
BE717950D BE717950A (de) 1967-07-11 1968-07-11

Country Status (6)

Country Link
AT (1) AT279623B (de)
BE (1) BE717950A (de)
ES (1) ES355977A1 (de)
FR (1) FR7681M (de)
IL (1) IL30342A0 (de)
NL (1) NL6809850A (de)

Also Published As

Publication number Publication date
NL6809850A (de) 1969-01-14
ES355977A1 (es) 1970-01-01
FR7681M (de) 1970-02-16
AT279623B (de) 1970-03-10
IL30342A0 (en) 1968-09-26

Similar Documents

Publication Publication Date Title
SU1003756A3 (ru) Способ получени 4-замещенных производных имидазолидин-2-она
US5075338A (en) Method of treatment of learning deficiency
EP0233106A1 (de) (-)-Benzhydrylsulfinylacetamid, Verfahren zur Herstellung und Verwendung in der Therapie
EP0074863B1 (de) Pyridazin-Derivat mit einer Wirkung auf das Zentralnervensystem
EP0506539A1 (de) Heterozyklische Alkylamide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
CH643546A5 (fr) Procede pour la preparation de derives d'hydantoine.
EP0117196B1 (de) N-Iminopyridinium-Betain-Derivate, ihre Herstellung und ihre Verwendung als Arzneimittel
FR2612517A1 (fr) Derives de benzoxazine, procedes de preparation de ces derives et compositions pharmaceutiques les contenant
FR2476071A1 (fr) Nouveaux acides 2-amino-3-(a-hydroxybenzyl)-phenylacetiques et leurs esters et amides, utiles notamment comme agents anti-inflammatoires, et compositions pharmaceutiques les contenant
CA1082716A (fr) Procede de preparation de nouveaux derives de 5- thiazole methane amine
LU87129A1 (fr) Nouvel acide piperazinecarboxylique,sa preparation et son utilisation comme medicament
FR2499981A1 (fr) Acides amino-2 halogenobenzoyl-3 methylphenylacetiques et leurs esters et sels utiles comme medicaments anti-inflammatoires et analgesiques
BE717950A (de)
EP0445025A2 (de) Erdalkalimetallsalze der Oxapolysäuren, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
EP0001021A2 (de) Derivate pentacyclischer Alkaloide, Verfahren zu deren Herstellung, Anwendung für die Synthese von Produkten der Eburnamoningruppe und pharmazeutische Zusammensetzungen
DE2427207A1 (de) Verfahren zur herstellung von kondensierten pyrrolmercapto-verbindungen
EP0183577B1 (de) Auf das Zentralnervensystem wirksame Thiadiazolderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
US3661975A (en) N-acetyl-n-(2,4,6-triiodo-3-aminophenyl)-beta-amino-isobutyric acid
WO2000063170A1 (fr) Derives de cyclobutene-3,4-dione en tant qu'inhibiteurs de la phosphodiesterase 5
CH648295A5 (fr) Acides 2-amino-3-(alkylthiobenzyl)-phenylacetiques et leurs derives.
FR2653999A1 (fr) Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
EP0135402B1 (de) Periphere Opiat-Antagoniste, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
CA1161444A (fr) Procede de preparation de derives du cycloheptindolol et de leurs sels avec les acides
EP0039809A2 (de) Substituierte 2-Amino-5-halogen-benzothiazole, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3014775C2 (de)